The role of protease inhibitor therapy in children with HIV infection (Q34783374)

4 August 2017

1 reference

title

The role of protease inhibitor therapy in children with HIV infection (English)

1 reference

4 August 2017

2

Ram Yogev

1 reference

4 August 2017

Patrick J Gavin

1

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

4

1 reference

4 August 2017

issue

9

1 reference

4 August 2017

page(s)

581-607

1 reference

Crystalluria and urinary tract abnormalities associated with indinavir

4 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165/00128072-200204090-00004

Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165/00128072-200204090-00004

Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants

21 January 2018

1 reference

12 December 2020

In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies

1 reference

12 December 2020

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

12 December 2020

A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virus

1 reference

12 December 2020

Saquinavir soft-gel capsule formulation. A review of its use in patients with HIV infection

1 reference

12 December 2020

Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers

1 reference

12 December 2020

Complete nucleotide sequence of the AIDS virus, HTLV-III

1 reference

12 December 2020

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

12 December 2020

Natural History of HIV-1 Cell-Free Viremia

1 reference

12 December 2020

Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate

1 reference

12 December 2020

Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children

1 reference

12 December 2020

Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection.

1 reference

12 December 2020

The accuracy of reverse transcriptase from HIV-1.

1 reference

12 December 2020

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team

1 reference

12 December 2020

Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus

1 reference

12 December 2020

Indinavir pharmacokinetics and parmacodynamics in children with human immunodeficiency virus infection

1 reference

12 December 2020

Resistance and cross-resistance with saquinavir and other HIV protease inhibitors: theory and practice

1 reference

12 December 2020

Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells

1 reference

12 December 2020

Nelfinavir. A review of its therapeutic efficacy in HIV infection

1 reference

12 December 2020

Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children

1 reference

12 December 2020

Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children

1 reference

12 December 2020

Rational design of peptide-based HIV proteinase inhibitors

1 reference

12 December 2020

Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus

1 reference

12 December 2020

The cost effectiveness of combination antiretroviral therapy for HIV disease.

1 reference

12 December 2020

Evolution and transmission of stable CTL escape mutations in HIV infection

1 reference

12 December 2020

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

1 reference

12 December 2020

Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in human immunodeficiency virus type 1-infected children

1 reference

12 December 2020

Spontaneous bleeding associated with the use of the protease inhibitor ritonavir in a hemophiliac patient with human immunodeficiency virus infection

1 reference

12 December 2020

Amprenavir: a review of its clinical potential in patients with HIV infection

1 reference

12 December 2020

Predictive value of quantitative plasma HIV RNA and CD4 lymphocyte count in HIV-infected infants and children

1 reference

12 December 2020

Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus

1 reference

12 December 2020

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

12 December 2020

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

12 December 2020

Decreased needs for hospital care and antibiotics in children with advanced HIV-1 disease after protease inhibitor-containing combination therapy

1 reference

12 December 2020

Anti-retroviral therapy for HIV-infected children--toward maximal effectiveness

1 reference

12 December 2020

Protease inhibitor therapy in children with perinatally acquired HIV infection

1 reference

12 December 2020

Adverse effects of antiretroviral therapy

1 reference

12 December 2020

Ritonavir promotes increased growth in HIV-infected children. Paediatric AIDS Group of Switzerland

1 reference

12 December 2020

HIV-1 protease inhibitors. A review for clinicians

1 reference

12 December 2020

Children with HIV infection: special cases

1 reference

12 December 2020

Comparison of ritonavir plus saquinavir- and nelfinavir plus saquinavir-containing regimens as salvage therapy in children with human immunodeficiency type 1 infection.

1 reference

12 December 2020

Interactions among drugs for HIV and opportunistic infections

1 reference

12 December 2020

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

1 reference

12 December 2020

Characteristics of human immunodeficiency virus-infected children at the time of death: an experience in the 1990s

1 reference

12 December 2020

Antiretroviral therapy of HIV infection in children

1 reference

12 December 2020

Lymphocyte subsets in healthy children during the first 5 years of life

1 reference

12 December 2020

Antiretroviral treatment in 1998.

1 reference

12 December 2020

Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors

1 reference

12 December 2020

Indinavir in cerebrospinal fluid of HIV-1-infected patients

1 reference

12 December 2020

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

1 reference

12 December 2020

Choosing the best initial therapy for HIV-1 infection

1 reference

12 December 2020

Effect of two novel inhibitors of the human immunodeficiency virus protease on the maturation of the HIV gag and gag-pol polyproteins

1 reference

12 December 2020

Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1.

1 reference

12 December 2020

Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites

1 reference

12 December 2020

Time to hit HIV, early and hard.

1 reference

12 December 2020

Viral dynamics of HIV: implications for drug development and therapeutic strategies

1 reference

12 December 2020

HTLV-III gag protein is processed in yeast cells by the virus pol-protease

1 reference

12 December 2020

Patient compliance and drug failure in protease inhibitor monotherapy

1 reference

12 December 2020

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

12 December 2020

Can Perinatal HIV Infection Be Eliminated in the United States?

1 reference

12 December 2020

The HIV-1 protease as a therapeutic target for AIDS

1 reference

12 December 2020

A phase I/II study of the protease inhibitor indinavir in children with HIV infection

1 reference

12 December 2020

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

12 December 2020

Combination antiretroviral therapy including ritonavir in children infected with human immunodeficiency

1 reference

12 December 2020

Nelfinavir: an update on its use in HIV infection

1 reference

12 December 2020

Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector

1 reference

12 December 2020

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

12 December 2020

HIV-protease inhibitors

1 reference

12 December 2020

Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection

1 reference

12 December 2020

Single-dose pharmacokinetics of indinavir and the effect of food.

1 reference

12 December 2020

The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobuli

1 reference

12 December 2020

Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

1 reference

12 December 2020

1 reference

12 December 2020

Drug compliance in pediatrics. Clinical and research issues

1 reference

12 December 2020

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

1 reference

12 December 2020

A structural model for the retroviral proteases.

1 reference

12 December 2020

Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

1 reference

12 December 2020

Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1

1 reference

12 December 2020

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

1 reference

12 December 2020

CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)

1 reference

12 December 2020

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

12 December 2020

Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants

1 reference

12 December 2020

ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease

1 reference

12 December 2020

Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Resistance to human immunodeficiency virus type 1 protease inhibitors.

1 reference

12 December 2020

Attaining higher goals in HIV treatment: the central importance of adherence

1 reference

12 December 2020

A Phase I/II Study of the Protease Inhibitor Ritonavir in Children With Human Immunodeficiency Virus Infection

1 reference

12 December 2020

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

1 reference

12 December 2020

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

12 December 2020

Neurodevelopmental/Neuroradiologic Recovery of a Child Infected With HIV After Treatment With Combination Antiretroviral Therapy Using the HIV-Specific Protease Inhibitor Ritonavir

1 reference

12 December 2020

Loss of Viral Fitness Associated with Multiple Gag and Gag-Pol Processing Defects in Human Immunodeficiency Virus Type 1 Variants Selected for Resistance to Protease Inhibitors In Vivo

1 reference

12 December 2020

Fidelity of HIV-1 reverse transcriptase

1 reference

12 December 2020

Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing

1 reference

12 December 2020

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

1 reference

12 December 2020

Rash as side-effect of nelfinavir in children

1 reference

12 December 2020

A one year experience: T cell responses and viral replication in children with advanced human immunodeficiency virus type 1 disease treated with combination therapy including ritonavir

1 reference

12 December 2020

Abnormal body-fat distribution in HIV-1-infected children on antiretrovirals

1 reference

12 December 2020

Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children

1 reference

12 December 2020

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

12 December 2020

The era of adherence to HIV therapy

1 reference

12 December 2020

Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team

1 reference

12 December 2020

HIV protease inhibitors: pharmacologic and metabolic distinctions

1 reference

12 December 2020

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies.

1 reference

12 December 2020

Viral counts count in HIV infection

1 reference

12 December 2020

Drug interactions in patients infected with human immunodeficiency virus

1 reference

12 December 2020

10.2165/00128072-200204090-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1047130150

0 references

1 reference